Viatris Inc. (VTRS)

AI Score

Unlock

7.51

-0.03 (-0.40%)

At close: Apr 14, 2025, 1:06 PM

-0.40% (1D)

Bid	7.5
Market Cap	8.96B
Revenue (ttm)	14.73B
Net Income (ttm)	-634.2M
EPS (ttm)	-0.53
PE Ratio (ttm)	-14.17
Forward PE	4.24
Analyst	Hold

Ask	7.52
Volume	4,794,784
Avg. Volume (20D)	14,906,677.4
Open	7.67
Previous Close	7.54
Day's Range	7.42 - 7.68
52-Week Range	6.85 - 13.55
Beta	0.91

About VTRS

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, end...

Sector Healthcare

IPO Date Mar 17, 1980

Employees 32,000

Stock Exchange NASDAQ

Ticker Symbol VTRS

Website https://www.viatris.com

Full Company Profile

Analyst Forecast

According to 4 analyst ratings, the average rating for VTRS stock is "Hold." The 12-month stock price forecast is $10, which is an increase of 33.16% from the latest price.

Stock Forecasts

Next Earnings Release

Viatris Inc. is scheduled to release its earnings on May 8, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

-0.13%

Viatris shares are trading lower after the company... Unlock content with Pro Subscription

1 month ago

-15.21%

Viatris shares are trading lower after the company reported Q4 EPS and sales below estimates, and issued FY25 revenue and EPS guidance below estimates.

News

Just now · accessnewswire.com

VTRS LAWSUIT ALERT: Levi & Korsinsky Notifies Viatris Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, NY / ACCESS Newswire / April 14, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, f...

NEW YORK CITY, NY / ACCESS Newswire / April 14, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Viatr...

Just now · businesswire.com

VTRS INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Viatris business and prospects, resulting in its stock trading at inflated prices.

20 hours ago · accessnewswire.com

Viatris Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - VTRS

NEW YORK, NY / ACCESS Newswire / April 13, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, f...